Hemab Therapeutics Holdings (COAG)
Nasdaq • COAG • US4234941031
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 21.1% of free float sold short, 10.5 days to cover, cost to borrow 2.32%. Sign up for live short interest data.
Market Cap
2.29b USD | # 3683 in US
Volume
458.57k shares | 18.55m USD
Shares Outstanding
46.71m
Free Float Shares
43.48% | 20.31m
